BioAge Labs (BIOA) Asset Utilization Ratio (2025 - 2026)
BioAge Labs (BIOA) posted Asset Utilization Ratio of 0.03 for Q1 2026, down 0.64% sequentially from 0.03 in Q4 2025, and up 620.74% YoY from 0.0 in Q1 2025.
BioAge Labs (BIOA) Asset Utilization Ratio (2025 - 2026) Analysis & Trends
BioAge Labs has reported Asset Utilization Ratio for 2 years, with the latest figure at 0.03 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 620.74% year-over-year to 0.03 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03 (up 620.74% YoY) and the FY2025 annual result came in at 0.03, changed N/A from the prior year.
- Asset Utilization Ratio eased to 0.03 in Q1 2026 per BIOA's latest filing, from 0.03 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.03 in Q4 2025 and troughed at 0.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | BioAge Labs | 434.04 Mn | 434.04 Mn | -14.23 Mn | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.03 |
| Mar 31, 2026 | 0.03 |
| Dec 31, 2025 | 0.03 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.00 |